INSULINORESISTANCE IN PATIENTS WITH FIBROCYSTIC MASTOPATHY, AND THE EFFECT OF METFORMIN ON IT

ORIGINAL SOURCE
Originally published in South Aral Region Medical Journal; Vol. 1 No. 3 (2025): JANUBIY OROL BO‘YI TIBBIYOT JURNALI; 86-91.

Yuldashev, Otabek and Fayzullaev, Bakhrom and Rustamova, Saodat and Boboeva, Dinora (2026) INSULINORESISTANCE IN PATIENTS WITH FIBROCYSTIC MASTOPATHY, AND THE EFFECT OF METFORMIN ON IT. South Aral Region Medical Journal; Vol. 1 No. 3 (2025): JANUBIY OROL BO‘YI TIBBIYOT JURNALI; 86-91.

[thumbnail of 31.pdf] PDF
31.pdf - Published Version

Download (385kB)

Abstract

Mastopathy is the most common disease in women, accounting for 90% of the flow of diseases in mammology. The etiology of fibrocystic mastopathy has not been fully elucidated, but many studied risk factors include endocrine disorders, particularly insulin resistance and thyroid disease

Item Type: Article
Additional Information: Imported from South Aral Region Medical Journal
SWORD Depositor: Admin User
Depositing User: Admin User
Date Deposited: 21 Sep 2026 22:59
Last Modified: 21 Sep 2026 22:59
URI: https://universalpublishings.uz/id/eprint/2811

Actions (login required)

View Item
View Item